COX-2 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy and celecoxib: a quantitative immunohistochemical analysis of RTOG C0128 (Q36335351)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	COX-2 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy and celecoxib: a quantitative immunohistochemical analysis of RTOG C0128	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

COX-2 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy and celecoxib: a quantitative immunohistochemical analysis of RTOG C0128 (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

chemoradiotherapy

0 references

immunohistochemistry

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

Joanne B. Weidhaas

object named as

Joanne B Weidhaas

7

0 references

object named as

Adam P Dicker

6

0 references

author name string

Corinne M Doll

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Kathryn Winter

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

David K Gaffney

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Janice K Ryu

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Anuja Jhingran

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Brigitte E Miller

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Anthony M Magliocco

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

1 January 2013

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

International Journal of Gynecological Cancer

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

23

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

176-183

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

30 September 2017

The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

30 September 2017

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

30 September 2017

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

30 September 2017

Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

29 June 2018

Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

22 September 2018

Low ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation alone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

22 September 2018

Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

22 September 2018

COX-2 expression in gastric cancer and its relationship with angiogenesis using tissue microarray

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

22 September 2018

Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

22 September 2018

Quantification of angiogenesis in cervical cancer: a comparison among three endothelial cell markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

22 September 2018

Automated subcellular localization and quantification of protein expression in tissue microarrays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

22 September 2018

Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

22 September 2018

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

22 September 2018

A prospective phase I–II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4665619

5 December 2018

Neoangiogenesis in cervical cancer: focus on CD34 assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23221733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative taxane-based chemotherapy and celecoxib for carcinoma of the esophagus and gastroesophageal junction: results of a phase 2 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23221733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of concurrent chemoradiation with weekly cisplatin ± low-dose celecoxib in locally advanced undifferentiated nasopharyngeal carcinoma: a phase II-III clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23221733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23221733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/23221733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23221733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23221733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expressions

1 reference

https://pubmed.ncbi.nlm.nih.gov/23221733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128

1 reference

https://pubmed.ncbi.nlm.nih.gov/23221733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/IGC.0B013E3182791EFC

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36335351&oldid=2043351906"